Copertina

Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Natthawadee Laokulrath, Mihir Gudi, Syed Ahmed Salahuddin, Angela Phek Yoon Chong, Cristine Ding, Jabed Iqbal, Wei Qiang Leow, Benjamin Yongcheng Tan, Gary Tse, Emad Rakha, Puay Hoon Tan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Histopathology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Retesting of oestrogen receptor, progesterone receptor and HER2 status of invasive carcinoma of the breast after neoadjuvant chemotherapy
di: Andrew H S Lee, et al.
Pubblicazione: (2025)

Breast core needle biopsy diagnosis and personalized treatment: navigating pitfalls and challenging lesions
di: Emad A. Rakha, et al.
Pubblicazione: (2026)

HER2‐positive grade 1 invasive carcinomas of the breast
di: Andrew H S Lee, et al.
Pubblicazione: (2024)

Molecular pathology of phyllodes tumours of the breast—much more than MED12
di: Jia‐Min B Pang, et al.
Pubblicazione: (2026)

Outcome prediction of oestrogen receptor‐positive breast cancer based on a panel of oestrogen receptor‐regulated genes
di: Shorouk Makhlouf, et al.
Pubblicazione: (2025)

Discordance of human epidermal growth factor receptor 2‐low status between breast primary and distant metastases with clinical–pathological correlation
di: Ellen Yang, et al.
Pubblicazione: (2024)

Nottingham prognostic x (NPx): a risk stratification tool in ER‐positive HER2‐negative breast cancer: a validation study
di: Ayat G Lashen, et al.
Pubblicazione: (2024)

Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy
di: Monalyn Marabi, et al.
Pubblicazione: (2026)

Artificial intelligence modelling in grading breast phyllodes tumours
di: Jessica Ee Ting Koong, et al.
Pubblicazione: (2026)

Development of a deep‐learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2‐low cases
di: Pierre‐Antoine Bannier, et al.
Pubblicazione: (2024)

Nuclear morphological characterisation of lobular carcinoma variants: a morphometric study
di: Ayaka Katayama, et al.
Pubblicazione: (2024)

Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast
di: Clarissa Jing Wen Wong, et al.
Pubblicazione: (2024)

Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)
di: Ian Ellis, et al.
Pubblicazione: (2024)

A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)
di: Veerle Bossuyt, et al.
Pubblicazione: (2024)

Diagnostic interobserver variability of atypia assessment in columnar cell lesions among a group of expert breast pathologists in the United Kingdom and the Republic of Ireland, on behalf of the UK national coordinating committee for breast pathology
di: Soha El Sheikh, et al.
Pubblicazione: (2024)

The first reported case of effective targeted therapy in extrahepatic cholangiocarcinoma harboring an epidermal growth factor receptor exon 19 deletion
di: Ling‐Jen Hung, et al.
Pubblicazione: (2025)

Folate receptor alpha ( FRα / FOLR1 ) and HER2 immunohistochemical staining in high‐grade endometrial carcinoma with aberrant p53 expression
di: Austin McHenry, et al.
Pubblicazione: (2025)

Recent advancements in biomarkers and molecular diagnostics in hormonal receptor‐positive breast cancer
di: Yihong Wang, et al.
Pubblicazione: (2024)

Loss of hormone receptor expression in breast tissue following pre‐surgical therapy with an SERD
di: Francesco de Napoli, et al.
Pubblicazione: (2025)

Quantitative comparison of immunohistochemical HER2‐low detection in an interlaboratory study
di: Maaike Anna Hempenius, et al.
Pubblicazione: (2024)

HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls
di: Huina Zhang, et al.
Pubblicazione: (2024)

Genetic and immunohistochemical studies identify recurrent ACTB mutations and PTEN alterations in tubular adenomas of the breast
di: Hnin Ingyin, et al.
Pubblicazione: (2025)

Nonneoplastic and neoplastic sclerosing lesions of the breast
di: Gulisa Turashvili
Pubblicazione: (2024)

Characterizing pseudoangiomatous stromal hyperplasia ( PASH ) of the breast
di: Rahul Koshy, et al.
Pubblicazione: (2026)

MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple‐negative breast cancers
di: Harsh Batra, et al.
Pubblicazione: (2024)

TRPS1 expression in neuroendocrine neoplasms of breast and other organs
di: Qiqi Ye, et al.
Pubblicazione: (2025)

The clinicopathological and molecular features of primary high‐grade neuroendocrine tumour in the breast
di: Ruping Hong, et al.
Pubblicazione: (2024)

Decision‐making in breast pathology reporting: the effect of clinical relevant thresholds
di: Zeynep E Kain, et al.
Pubblicazione: (2025)

Diagnostic pitfall: GATA3 expression in mesonephric/mesonephric‐like adenocarcinoma involving the breast
di: Hala Alnuaim, et al.
Pubblicazione: (2025)

Optimizing breast core needle biopsy biomarker throughput using an AI ‐based workflow
di: Frederik Deman, et al.
Pubblicazione: (2026)

Genomic and clinicopathological characteristics of low oncotype recurrent score breast cancers with subsequent metastasis
di: Liu Liu, et al.
Pubblicazione: (2026)

The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile
di: Mona Alafraidi, et al.
Pubblicazione: (2024)

WHO classification of skin tumours: key updates in the fifth edition
di: Gabrielle Goldman‐Lévy, et al.
Pubblicazione: (2025)

E‐cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes
di: Seyed R Taha, et al.
Pubblicazione: (2024)

Male breast atypical ductal hyperplasia (ADH): clinicopathological insights from a rare cohort
di: Reham Al‐Refai, et al.
Pubblicazione: (2025)

Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours
di: Gregor Krings, et al.
Pubblicazione: (2024)

DCIS‐like invasive carcinoma of the breast with tumour‐associated microvasculature mimicking myoepithelium: a diagnostic pitfall
di: Taylor Salisbury, et al.
Pubblicazione: (2025)

NTRK‐fusion spindle cell tumour in the breast: expanding the differential of challenging spindle cell lesions on core biopsy
di: Christopher J Schwartz, et al.
Pubblicazione: (2025)

Correction to ‘A simple digital image analysis system for automated Ki67 assessment in primary breast cancer’
Pubblicazione: (2026)

Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features
di: Mingfang Sun, et al.
Pubblicazione: (2025)